Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 124,618 | 138,066 | 149,706 | 117,075 | 164,594 |
| Gross Profit | 124,618 | 138,066 | 149,706 | 117,075 | 164,594 |
| Operating Expenses | 8,450 | 7,429 | 7,666 | 17,726 | 5,686 |
| Operating Income | 116,168 | 130,637 | 142,040 | 99,349 | 158,908 |
| Interest Expense | 5,901 | 7,199 | 8,610 | 9,441 | 9,387 |
| Other Income | 87 | 121 | 86 | 108 | 75 |
| Pre-tax Income | 110,354 | 123,559 | 133,516 | 90,016 | 149,596 |
| Income Tax | 40,895 | 45,295 | 49,018 | 34,945 | 47,361 |
| Net Income Continuous | 69,459 | 78,264 | 84,498 | 55,071 | 102,235 |
| Net Income | $69,459 | $78,264 | $84,498 | $55,071 | $102,235 |
| EPS Basic Total Ops | 0.42 | 0.48 | 0.52 | 0.35 | 0.64 |
| EPS Basic Continuous Ops | 0.42 | 0.48 | 0.52 | 0.34 | 0.64 |
| EPS Diluted Total Ops | 0.42 | 0.47 | 0.50 | 0.29 | 0.61 |
| EPS Diluted Continuous Ops | 0.42 | 0.47 | 0.50 | 0.29 | 0.61 |
| EBITDA(a) | $118,711 | $133,791 | $146,116 | $104,582 | $162,763 |